Literature DB >> 19191709

Synthesis of deoxytetrahydrouridine.

Jolanna Norton1, Hiroshi Matsuo, Shana J Sturla.   

Abstract

The alpha-hydroxyamido functionality of 2'-deoxytetrahydrouridine (dTHU) makes this seemingly simple and generally useful compound difficult to obtain. Reported synthetic strategies produce extremely poor yields and multiple products, and full characterization data is not available. Described herein is a two-step approach for synthesizing dTHU in increased yields and purity; stability concerns are also addressed. Catalytic reduction (5% Rh/alumina) of 2'-deoxyuridine, followed by reduction with sodium borohydride as a limiting reagent, produces dTHU and limits formation of side products. Evidence was obtained for formation of a methoxy-substituted analogue during purification. By this strategy, dTHU of >95% purity can be obtained in 40% yield on a 150 mg scale.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19191709      PMCID: PMC2880644          DOI: 10.1021/jo802599v

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  12 in total

1.  Tetrahydrodeoxyuridylate: a potent inhibitor of deoxycytidylate deaminase.

Authors:  F Maley; G F Maley
Journal:  Arch Biochem Biophys       Date:  1971-06       Impact factor: 4.013

2.  Selective photoreduction of nucleotides and nucleic acids. II. Mechanism of the two-step reduction of thymidine.

Authors:  G Ballé; P Cerutti; B Witkop
Journal:  J Am Chem Soc       Date:  1966-09-05       Impact factor: 15.419

3.  Nucleic acids. IV. The catalytic reduction of pyrimidine nucleosides (human liver deaminase inhibitors).

Authors:  A R Hanze
Journal:  J Am Chem Soc       Date:  1967-12-06       Impact factor: 15.419

4.  Antiherpes virus activity and effect on deoxyribonucleoside triphosphate pools of (E)-5-(2-bromovinyl)-2'-deoxycytidine in combination with deaminase inhibitors.

Authors:  P J Aduma; S V Gupta; E De Clercq
Journal:  Antiviral Res       Date:  1990-03       Impact factor: 5.970

5.  Crystal structure of the tetrameric cytidine deaminase from Bacillus subtilis at 2.0 A resolution.

Authors:  Eva Johansson; Nina Mejlhede; Jan Neuhard; Sine Larsen
Journal:  Biochemistry       Date:  2002-02-26       Impact factor: 3.162

6.  Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.

Authors:  Ann M Sheehy; Nathan C Gaddis; Jonathan D Choi; Michael H Malim
Journal:  Nature       Date:  2002-07-14       Impact factor: 49.962

7.  Structural, kinetic, and mutational studies of the zinc ion environment in tetrameric cytidine deaminase.

Authors:  Eva Johansson; Jan Neuhard; Martin Willemoës; Sine Larsen
Journal:  Biochemistry       Date:  2004-05-25       Impact factor: 3.162

8.  Nucleosides of 1,4-thiazin-3-one and derivatives as tetrahedral intermediate analogues of enzymes in pyrimidine nucleoside metabolism.

Authors:  T E Marcus; A Gundy; C H Levenson; R B Meyer
Journal:  J Med Chem       Date:  1988-08       Impact factor: 7.446

9.  Binding of pyrimidin-2-one ribonucleoside by cytidine deaminase as the transition-state analogue 3,4-dihydrouridine and the contribution of the 4-hydroxyl group to its binding affinity.

Authors:  L Frick; C Yang; V E Marquez; R Wolfenden
Journal:  Biochemistry       Date:  1989-11-28       Impact factor: 3.162

10.  Modulation of deoxynucleotide metabolism by the deoxycytidylate deaminase inhibitor 3,4,5,6-tetrahydrodeoxyuridine.

Authors:  V Heinemann; W Plunkett
Journal:  Biochem Pharmacol       Date:  1989-11-15       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.